Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F E Jansen

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Neurology|December 28, 2006
Severe myoclonic epilepsy of infancy (Dravet syndrome): recognition and diagnosis in adultsF E Jansen, L G Sadleir, L A Harkin, et al.
Epilepsy & Behavior : E&B|July 31, 2023
Gastrointestinal and eating problems in SCN1A-related seizure disordersC A Minderhoud, A Postma, F E Jansen, et al.
Journal of Molecular Neuroscience : MN|April 29, 2016
Promoter-Specific Hypomethylation Correlates with IL-1β Overexpression in Tuberous Sclerosis Complex (TSC)A Fuso, A M Iyer, J van Scheppingen, et al.
Neurology|November 23, 2007
Overlapping neurologic and cognitive phenotypes in patients with TSC1 or TSC2 mutationsF E Jansen, O Braams, K L Vincken, et al.
Neurology|November 23, 2007
Cognitive impairment in tuberous sclerosis complex is a multifactorial conditionF E Jansen, K L Vincken, A Algra, et al.
Neuropathology and Applied Neurobiology|June 12, 2019
Increased matrix metalloproteinases expression in tuberous sclerosis complex: modulation by microRNA 146a and 147b in vitroD W M Broekaart, J van Scheppingen, J J Anink, et al.
Neuropathology and Applied Neurobiology|December 24, 2019
Chronic activation of anti-oxidant pathways and iron accumulation in epileptogenic malformationsT S Zimmer, G Ciriminna, A Arena, et al.
Glia|March 26, 2016
Expression of microRNAs miR21, miR146a, and miR155 in tuberous sclerosis complex cortical tubers and their regulation in human astrocytes and SEGA-derived cell culturesJ van Scheppingen, A M Iyer, A S Prabowo, et al.
BMC Psychiatry|January 4, 2024
Cannabidiol (Epidyolex®) for severe behavioral manifestations in patients with tuberous sclerosis complex, mucopolysaccharidosis type III and fragile X syndrome: protocol for a series of randomized, placebo-controlled N-of-1 trialsA R Müller, B den Hollander, P M van de Ven, et al.
AJNR. American Journal of Neuroradiology|August 1, 2020
Introduction of Ultra-High-Field MR Imaging in Infants: Preparations and FeasibilityK V Annink, N E van der Aa, J Dudink, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Neurology|December 28, 2006
Severe myoclonic epilepsy of infancy (Dravet syndrome): recognition and diagnosis in adultsF E Jansen, L G Sadleir, L A Harkin, et al.
Epilepsy & Behavior : E&B|July 31, 2023
Gastrointestinal and eating problems in SCN1A-related seizure disordersC A Minderhoud, A Postma, F E Jansen, et al.
Journal of Molecular Neuroscience : MN|April 29, 2016
Promoter-Specific Hypomethylation Correlates with IL-1β Overexpression in Tuberous Sclerosis Complex (TSC)A Fuso, A M Iyer, J van Scheppingen, et al.
Neurology|November 23, 2007
Overlapping neurologic and cognitive phenotypes in patients with TSC1 or TSC2 mutationsF E Jansen, O Braams, K L Vincken, et al.
Neurology|November 23, 2007
Cognitive impairment in tuberous sclerosis complex is a multifactorial conditionF E Jansen, K L Vincken, A Algra, et al.
Neuropathology and Applied Neurobiology|June 12, 2019
Increased matrix metalloproteinases expression in tuberous sclerosis complex: modulation by microRNA 146a and 147b in vitroD W M Broekaart, J van Scheppingen, J J Anink, et al.
Neuropathology and Applied Neurobiology|December 24, 2019
Chronic activation of anti-oxidant pathways and iron accumulation in epileptogenic malformationsT S Zimmer, G Ciriminna, A Arena, et al.
Glia|March 26, 2016
Expression of microRNAs miR21, miR146a, and miR155 in tuberous sclerosis complex cortical tubers and their regulation in human astrocytes and SEGA-derived cell culturesJ van Scheppingen, A M Iyer, A S Prabowo, et al.
BMC Psychiatry|January 4, 2024
Cannabidiol (Epidyolex®) for severe behavioral manifestations in patients with tuberous sclerosis complex, mucopolysaccharidosis type III and fragile X syndrome: protocol for a series of randomized, placebo-controlled N-of-1 trialsA R Müller, B den Hollander, P M van de Ven, et al.
AJNR. American Journal of Neuroradiology|August 1, 2020
Introduction of Ultra-High-Field MR Imaging in Infants: Preparations and FeasibilityK V Annink, N E van der Aa, J Dudink, et al.
Pageof 3